Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tamura, T.
Right arrow Articles by Bergman, S. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tamura, T.
Right arrow Articles by Bergman, S. M.

Journal of the American Society of Nephrology, Vol 7, 2414-2418, Copyright © 1996 by American Society of Nephrology


REGULAR ARTICLES

Homocysteine and folate concentrations in blood from patients treated with hemodialysis

T Tamura, KE Johnston and SM Bergman
Department of Nutrition Sciences, University of Alabama at Birmingham 35294-3360, USA.

Plasma homocysteine and plasma and erythrocyte folate concentrations before and after hemodialysis were measured in 31 patients with ESRD. Homocysteine and folate were measured by HPLC-fluorometric and microbiological methods, respectively. The mean plasma homocysteine level declined from 36.8 to 24.2 mumol/L during hemodialysis, indicating that homocysteine can be partly removed by hemodialysis (P < 0.0001). Mean plasma folate concentration before hemodialysis was 46.4 nmol/L and decreased to 25.9 nmol/L after hemodialysis (P < 0.0001), whereas mean erythrocyte folate concentration did not change (1295 and 1385 nmol/L before and after hemodialysis, respectively). Plasma folate concentrations showed a significant negative correlation with homocysteine concentrations before and after hemodialysis (r = -0.53, P < 0.003, and r = -0.59, P < 0.001, respectively). Furthermore, there were significant negative correlations between plasma homocysteine and erythrocyte folate concentrations both before (r = -0.60, P < 0.0005) and after hemodialysis (r = -0.49, P < 0.005). All patients had homocysteine concentrations over 12.0 mumol/L before hemodialysis, and only three had homocysteine concentrations lower than 12.0 mumol/L after hemodialysis. Although significant correlations existed between homocysteine and folate concentrations, the majority of the patients in this study appeared to have adequate folate nutriture as assessed by blood folate concentrations. It remains to be determined whether patients with ESRD have an altered homocysteine metabolism.


This article has been cited by other articles:


Home page
CJASNHome page
B. L. Urquhart, D. J. Freeman, M. J. Cutler, R. Mainra, J. D. Spence, and A. A. House
Mesna for Treatment of Hyperhomocysteinemia in Hemodialysis Patients: A Placebo-Controlled, Double-Blind, Randomized Trial
Clin. J. Am. Soc. Nephrol., July 1, 2008; 3(4): 1041 - 1047.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
H. Schiffl and S. M. Lang
Folic acid deficiency modifies the haematopoietic response to recombinant human erythropoietin in maintenance dialysis patients
Nephrol. Dial. Transplant., January 1, 2006; 21(1): 133 - 137.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
T. Tamura, R. L. Goldenberg, V. R. Chapman, K. E. Johnston, S. L. Ramey, and K. G. Nelson
Folate Status of Mothers During Pregnancy and Mental and Psychomotor Development of Their Children at Five Years of Age
Pediatrics, September 1, 2005; 116(3): 703 - 708.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
M. F. Picciano, S. G West, A. L Ruch, P. M Kris-Etherton, G. Zhao, K. E Johnston, D. H Maddox, V. K Fishell, D. B Dirienzo, and T. Tamura
Effect of cow milk on food folate bioavailability in young women
Am. J. Clinical Nutrition, December 1, 2004; 80(6): 1565 - 1569.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
P. Muntner, L. L. Hamm, J. W. Kusek, J. Chen, P. K. Whelton, and J. He
The Prevalence of Nontraditional Risk Factors for Coronary Heart Disease in Patients with Chronic Kidney Disease
Ann Intern Med, January 6, 2004; 140(1): 9 - 17.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
A. S. D. Vriese, M. Langlois, D. Bernard, I. Geerolf, L. Stevens, J. R. Boelaert, M. Schurgers, and E. Matthys
Effect of dialyser membrane pore size on plasma homocysteine levels in haemodialysis patients
Nephrol. Dial. Transplant., December 1, 2003; 18(12): 2596 - 2600.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
K. Shinohara, T. Shoji, M. Emoto, H. Tahara, H. Koyama, E. Ishimura, T. Miki, T. Tabata, and Y. Nishizawa
Insulin Resistance as an Independent Predictor of Cardiovascular Mortality in Patients with End-Stage Renal Disease
J. Am. Soc. Nephrol., July 1, 2002; 13(7): 1894 - 1900.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
H. KIMURA, F. GEJYO, S. SUZUKI, and R. MIYAZAKI
The C677T Methylenetetrahydrofolate Reductase Gene Mutation in Hemodialysis Patients
J. Am. Soc. Nephrol., May 1, 2000; 11(5): 885 - 893.
[Abstract] [Full Text]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP